Cannabis has emerged as a big winner in the 2020 U.S. presidential election. All five states that voted on cannabis legalization passed their ballot measures. That list includes:
- Arizona: recreational cannabis
- New Jersey: recreational cannabis
- Montana: recreational cannabis
- South Dakota: recreational and medical cannabis
- Mississippi: medical cannabis
This is another big step forward for the U.S. cannabis industry.
33 states have already legalized medical or recreational cannabis. Adding five more states to the mix will add billions in annual sales. The growing green wave has analysts predicting enormous growth for the U.S. cannabis industry in the next five years.
U.S. Cannabis Industry Setting Up For Major Growth
Here are some more details from mjbizdaily.com.
Retail sales of medical and recreational cannabis in the United States are on pace to eclipse $15 billion by the end of 2020, an increase of approximately 40% over 2019 sales figures, according to exclusive projections from the 2020 edition of the Marijuana Business Factbook.
Total U.S. sales could rise as high as $37 billion by 2024, according to exclusive projections from the latest Factbook, which was released Monday at MJBizConNEXT Direct.
While the entire cannabis sector stands to benefit from this explosive growth, a popular group of early industry leaders could benefit the most.
This exclusive group of stocks benefits from a number of competitive advantages over its peer.
- They are the largest companies in the U.S. cannabis industry
- The companies operate in multiple states
- They own hard-to-get permits to grow and sell cannabis
- They have the best product portfolios
- Cash in the bank to fund more growth
3 Stocks to Play the Vote
Cresco Labs (CSE: CL, OTC: CRLBF) is an early leader in the U.S. cannabis industry. Headquartered in Chicago with a market cap of $1.5 billion, Cresco owns an impressive portfolio of cannabis assets. That includes 29 retail licenses, 18 dispensaries, and 15 production facilities. Cresco is positioned for long-term success in the cannabis industry.
Cresco shares have seen a big rebound from the COVID low in March. However, Cresco is still trading 40% below the all-time high from 2019. Take a look at the 2020 chart below.
Green Thumb Industries (CSE: GTI, OTC: GTBIF) is another early leader in the U.S. cannabis industry. Headquartered in Chicago, Illinois, Green Thumb has a market cap of $2.2 billion. This powerhouse company also owns and operates an impressive portfolio of cannabis assets. This portfolio includes licenses for 96 retail locations and 13 manufacturing facilities operating in 12 states.
In August, Green Thumb became the first U.S. cannabis company to report revenue of more than $100 million in one quarter. Green Thumb is also positioned for long-term success in the U.S. cannabis industry.
Green Thumb shares have also seen a big rebound from the COVID low in March. Nonetheless, these shares are still trading 20% below the 52-week high. Take a look at the 2020 chart below.
Curaleaf Holdings (CSE: CURL, OTC: CURLF) is the largest cannabis company in the U.S. with a market value of $4.8 billion. Headquartered in Wakefield, Massachusetts, Curaleaf just completed a $700 million acquisition that gives it the best cannabis portfolio in the industry. That includes operations in 23 states, 135 dispensary licenses, 88 operating dispensaries, 30 processing facilities, 22 cultivation facilitates, and more than 1.6 million square feet of cultivation capacity.
Curaleaf now has the best chance to be the first U.S. cannabis company to generate more than $1 billion in annual sales. After the acquisition, no other U.S. cannabis company comes close to Curaleaf’s portfolio of dispensaries, greenhouses, and processing facilities. This portfolio of cannabis assets should drive huge revenue growth in the next few years – particularly because U.S. cannabis sales are expected to surge.
Curaleaf has also seen a big rebound from the COVID low in March, but these shares are still trading 10% below the 52-week high. Take a look at the 2020 chart below.
Cannabis Stock Trades Will Do the Hard Work for You
Let me say it again — despite the incredible opportunity, not all cannabis stocks will do well. In fact, the cannabis industry is loaded with questionable companies that will probably fail.
Do you really have time to spend hours researching the cannabis industry? Are you confident that you can separate the winning companies from ones that could implode?
Don’t waste your time! Outsource the hard work to Cannabis Stock Trades.
Get the information you need to invest in the best cannabis stocks – the ones with solid footing and massive growth potential.
Author Michael Vodicka owns shares of Cresco Labs (CRLBF), Green Thumb Industries (GTBIF), and Curaleaf Holdings (CURLF).
About the Author & Cannabis Stock Trades
Michael Vodicka is an equity analyst with more than 20 years of experience trading and investing. His research has been featured in some of the industry’s most respected publications. He has been investing and leading investors in the cannabis sector since 2013.
Mr. Vodicka brings his expertise and guidance to the members of Cannabis Stock Trades.
Join Cannabis Stock Trades for Mr. Vodicka’s exclusive analysis, trade alerts, and model portfolio.